Cyclic hydroxamic acid as metalloproteinase inhibitors
US6858626B2 · kind B2 · utility
42Cited by
2References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 20, 2002 |
| Grant date | Feb 22, 2005 |
| Priority date | — |
| Expiry date | Feb 8, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application describes novel cyclic hydroxamic acids of formula I: or pharmaceutically acceptable salt forms thereof, wherein ring B is a 5-7 membered cyclic system containing from 0-2 heteroatoms selected from O, N, NRa, and S(O)p, and 0-1 carbonyl groups and the other variables are defined in the present specification, which are useful as metalloprotease inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.